Fever without a source in children: international comparison of guidelines.


Journal

World journal of pediatrics : WJP
ISSN: 1867-0687
Titre abrégé: World J Pediatr
Pays: Switzerland
ID NLM: 101278599

Informations de publication

Date de publication:
Feb 2023
Historique:
received: 27 01 2022
accepted: 17 08 2022
pubmed: 27 10 2022
medline: 17 2 2023
entrez: 26 10 2022
Statut: ppublish

Résumé

Fever without a source (FWS) in children poses a diagnostic challenge. To distinguish a self-limiting infection from a serious infection, multiple guidelines have been developed to aid physicians in the management of FWS. Currently, there is no comparison of existing FWS guidelines. This comparative review describes consistencies and differences in guideline definitions and diagnostic and therapeutic recommendations. A literature search was performed to include secondary care FWS guidelines of high-income countries, composed by national or regional pediatric or emergency care associations, available in English or Dutch. Ten guidelines of five high-income countries were included, with varying age ranges of children with FWS. In children younger than one month with FWS, the majority of the guidelines recommended laboratory testing, blood and urine culturing and antibiotic treatment irrespective of the clinical condition of the patient. Recommendations for blood culture and antibiotic treatment varied for children aged 1-3 months. In children aged above three months, urine culture recommendations were inconsistent, while all guidelines consistently recommended cerebral spinal fluid testing and antibiotic treatment exclusively for children with a high risk of serious infection. We found these guidelines broadly consistent, especially for children with FWS younger than one month. Guideline variation was seen most in the targeted age ranges and in recommendations for children aged 1-3 months and above three months of age. The findings of the current study can assist in harmonizing guideline development and future research for the management of children with FWS.

Sections du résumé

BACKGROUND BACKGROUND
Fever without a source (FWS) in children poses a diagnostic challenge. To distinguish a self-limiting infection from a serious infection, multiple guidelines have been developed to aid physicians in the management of FWS. Currently, there is no comparison of existing FWS guidelines.
METHODS METHODS
This comparative review describes consistencies and differences in guideline definitions and diagnostic and therapeutic recommendations. A literature search was performed to include secondary care FWS guidelines of high-income countries, composed by national or regional pediatric or emergency care associations, available in English or Dutch.
RESULTS RESULTS
Ten guidelines of five high-income countries were included, with varying age ranges of children with FWS. In children younger than one month with FWS, the majority of the guidelines recommended laboratory testing, blood and urine culturing and antibiotic treatment irrespective of the clinical condition of the patient. Recommendations for blood culture and antibiotic treatment varied for children aged 1-3 months. In children aged above three months, urine culture recommendations were inconsistent, while all guidelines consistently recommended cerebral spinal fluid testing and antibiotic treatment exclusively for children with a high risk of serious infection.
CONCLUSIONS CONCLUSIONS
We found these guidelines broadly consistent, especially for children with FWS younger than one month. Guideline variation was seen most in the targeted age ranges and in recommendations for children aged 1-3 months and above three months of age. The findings of the current study can assist in harmonizing guideline development and future research for the management of children with FWS.

Identifiants

pubmed: 36287322
doi: 10.1007/s12519-022-00611-8
pii: 10.1007/s12519-022-00611-8
pmc: PMC9928815
doi:

Substances chimiques

Anti-Bacterial Agents 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

120-128

Informations de copyright

© 2022. The Author(s).

Références

Pediatr Emerg Care. 2001 Apr;17(2):83-7
pubmed: 11334099
J Emerg Med. 2019 Jun;56(6):583-591
pubmed: 31014970
Eur J Pediatr. 2016 Aug;175(8):1023-9
pubmed: 27156106
Med Care. 2001 Aug;39(8 Suppl 2):II46-54
pubmed: 11583121
Pediatrics. 2021 Aug;148(2):
pubmed: 34281996
J Paediatr Child Health. 2018 Dec;54(12):1308-1313
pubmed: 29874409
BMJ Glob Health. 2019 Apr 11;4(2):e001315
pubmed: 31139449
Pediatric Health Med Ther. 2019 Nov 15;10:147-152
pubmed: 31814793
Pediatrics. 2014 Feb;133(2):187-95
pubmed: 24470644
Evid Rep Technol Assess (Full Rep). 2012 Mar;(205):1-297
pubmed: 24422856
Pediatrics. 2014 Oct;134(4):667-77
pubmed: 25266437
Pediatr Emerg Care. 2004 Sep;20(9):579-87
pubmed: 15599258
Arch Pediatr Adolesc Med. 2001 Sep;155(9):1057-62
pubmed: 11529809
Emerg Med J. 2012 May;29(5):379-82
pubmed: 21609944
Pediatrics. 2012 Dec;130(6):e1455-62
pubmed: 23129086
Ann Emerg Med. 1993 Jul;22(7):1198-210
pubmed: 8517575
Children (Basel). 2017 Sep 01;4(9):
pubmed: 28862659
Pediatr Infect Dis J. 2010 Apr;29(4):310-3
pubmed: 20216475
Pediatr Res. 2020 Jul;88(1):2-4
pubmed: 32193517
BMC Pediatr. 2020 Jan 13;20(1):16
pubmed: 31931759
Patient Educ Couns. 2020 Apr;103(4):750-763
pubmed: 31668490
Pediatr Infect Dis J. 2020 Dec;39(12):1075-1080
pubmed: 32858646
Ann Emerg Med. 2000 Dec;36(6):602-14
pubmed: 11097701
Pediatrics. 2017 Aug;140(2):
pubmed: 28679639
Glob Pediatr Health. 2019 Jul 25;6:2333794X19865447
pubmed: 31384632
Pediatr Clin North Am. 2013 Oct;60(5):1049-62
pubmed: 24093895
Crit Care. 2017 Mar 21;21(1):68
pubmed: 28320432
Pediatr Infect Dis J. 2018 Feb;37(2):113-118
pubmed: 28763426
Pediatrics. 2009 Aug;124(2):439-45
pubmed: 19620201

Auteurs

Sanne Graaf (S)

Department of Pediatrics, Tergooi Hospital, Rijksstraatweg 1, 1261 AN, Blaricum, The Netherlands. s.g.graaf@gmail.com.

Maya Wietske Keuning (MW)

Department of Pediatrics, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Dasja Pajkrt (D)

Department of Pediatric Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Frans Berend Plötz (FB)

Department of Pediatrics, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Department of Pediatric Infectious Diseases, Amsterdam University Medical Centers, Location Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH